Elevance Health announced a higher earnings outlook after posting stronger second‑quarter results. The insurer’s revenue climbed 3% to $50.47 billion, beating Wall Street’s $48.84 billion estimate.

The company’s profit stood at $1.46 billion, or $6.71 a share, versus last year’s $1.74 billion and $7.72 a share. Adjusted earnings were $7.45 a share, surpassing the $6.21 a share analysts had polled.

A higher benefit‑expense ratio and solid sales drove the upbeat guidance. Analysts noted the insurer’s improved cost structure and revenue помог. Wall Street Journal highlighted the company’s optimistic outlook.

Elevance Health’s revised forecast reflects stronger premiums and controlled claims, positioning the insurer favorably in the competitive health‑insurance market.